Centene Corporation has raised its full-year adjusted profit forecast, increasing earnings per share guidance to a range of $5.55 to $5.70, while unveiling a $3 billion stock repurchase program and a $1 billion debt repurchase plan. These moves come alongside plans to divest two pharmacy business units for approximately $2.8 billion and reduce its real estate footprint by 65%, all aimed at enhancing its financial health. Despite recent market volatility, including a 1.06% decline in share price, Centene maintains a solid local presence and continues to provide high-quality healthcare to millions.
“Centene · is committed to · local-based health care model · true”
“Centene · will maintain · strong local presence · true”
“Centene · does not need · the same square footage · true”
“Centene · is adapting to · a more modern work structure · true”
“Centene Corp · raised · full-year adjusted profit forecast · $5.55 to $5.70 per share”
“Centene Corp · compared · earlier profit forecast · between $5.40 and $5.55 per share”
“Centene Corp · increased · share buyback program · $3 billion”
“Centene Corp · launched · debt repurchase program · $1 billion”
“Centene Corp · planned · divestitures of pharmacy businesses · two units for about $2.8 billion”
“Centene Corp. · rallied · shares · 1.8%”
“Centene Corp. · raised · full-year profit and revenue outlook”
“Centene Corp. · added · stock repurchase program · $3.0 billion”
